Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit

Published: Apr 16, 2024 By Tristan Manalac

Courthouse_iStock, Mariakray

Pictured: Roman columns at the entrance of a U.S. courthouse/iStock, Mariakray

The U.S. District Court for the District of Massachusetts has granted Pfizer and BioNTech’s motion to put on hold Moderna‘s lawsuit against the companies over alleged patent infringement related to their COVID-19 vaccines, pending a review by the Patent Trial and Appeal Board, according to an electric docket order.

In his ruling on Friday, federal judge Richard Stearns wrote that he granted the stay “pending resolution of two inter partes review proceedings recently instituted by the Patent Trial and Appeal Board.” Waiting for the board’s decision would “simplify the issues in this case,” Stearns argued.

If the Patent Trial and Appeal Board (PTAB) ruled to cancel two of Moderna’s patent claims, “there would be no need to…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks